ICAM1 and bipolar disorder: Also, while the effects of psychotropic drugs on ICAM-1 and VCAM-1 are not fully elucidated, existing evidence suggests these medications, particularly antidepressants, could modulate the expression of these adhesion molecules, potentially contributing to their therapeutic efficacy and side effect profiles in bipolar disorder and MDD [24,25,26].